In the arithmetic of the markets, as prices of stocks and bonds fall, yields rise. And with markets in decline, some funds now offer double-digit yields—remarkable payouts at a time when Treasury bonds and many bank certificates of deposit yield well below 5%.
Investors have been dumping mutual funds at a record pace lately, withdrawing $195 billion in the last quarter of 2008, according to the Investment Company Institute, a mutual fund trade group.
Prior history of treatment with pulse methylprednisolone may increase the risk of fatal infection in pediatric lupus nephritis (LN) patients treated with IV cyclophosphamide (IVCY), researchers reported.
Elevated pulse pressure is associated with an increased risk of all-cause and cardiovascular death in patients on peritoneal dialysis (PD), according to a Canadian study.
Pretreatment C-reactive protein (CRP) levels can be a prognostic marker for patients with metastatic renal cell carcinoma (RCC), a Japanese study suggests.
The American Association for Justice (AAJ), formerly known as the Association of Trial Lawyers of America, said its analysis of new AMA data “adds to a growing body of research that proves physicians are not fleeing the profession because of medical liability.”
One way to limit liability risk is to minimize the likelihood of adverse drug reactions. Electronic prescribing systems are supposed to accomplish that goal by warning of patient allergies or possible interactions with other medications.
It was a case that would haunt Dr. E for the rest of his life and have devastating consequences for a young mother and her family.
Kibow Biotech, Inc., of Newtown Square, Pa., has launched Kibow Biotics, a scientifically formulated and clinically tested dietary supplement that helps maintain healthy kidney function.
Astellas Pharma US, Inc., of Deerfield, Ill., has announced the commercial availability of conivaptan hydrochloride injection (Vaprisol) premixed in 5% dextrose.
